Count | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
Thalidomide/*analogs & derivatives/*pharmacology/therapeutic use | 1 |
| 16 | |
| 17 | |
| 1 | |
| 5 | |
| 1 | |
| 14 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 6 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Thalidomide/*administration & dosage/adverse effects/therapeutic use | 1 |
Thalidomide/administration & dosage/adverse effects/*pharmacology | 1 |
Thalidomide/administration & dosage/adverse effects/*therapeutic use | 4 |
Thalidomide/administration & dosage/adverse effects/pharmacology | 1 |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 7 | |
| 1 | |
| 12 | |
| 1 | |
| 12 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 19 | |
| 1 | |
| 2 | |
| 2 | |